Effect of deferiprone or deferoxamine on right ventricular function in thalassemia major patients with myocardial iron overload (Q35143774)

6 August 2017

title

Effect of deferiprone or deferoxamine on right ventricular function in thalassemia major patients with myocardial iron overload (English)

1 reference

6 August 2017

1 reference

1 reference

15

Dudley J Pennell

1 reference

6 August 2017

Gillian C Smith

1

1 reference

6 August 2017

Francisco Alpendurada

2

1 reference

6 August 2017

John Paul Carpenter

3

1 reference

6 August 2017

Mohammed H Alam

4

1 reference

6 August 2017

Vasili Berdoukas

5

1 reference

6 August 2017

Markissia Karagiorga

6

1 reference

6 August 2017

Vasili Ladis

7

1 reference

6 August 2017

Antonio Piga

8

1 reference

6 August 2017

Athanassios Aessopos

9

1 reference

6 August 2017

Efstathios D Gotsis

10

1 reference

6 August 2017

Mark A Tanner

11

1 reference

6 August 2017

Mark A Westwood

12

1 reference

6 August 2017

Renzo Galanello

13

1 reference

6 August 2017

Michael Roughton

14

1 reference

6 August 2017

language of work or name

1 reference

6 July 2011

1 reference

Journal of Cardiovascular Magnetic Resonance

6 August 2017

published in

1 reference

6 August 2017

volume

13

1 reference

6 August 2017

page(s)

34

1 reference

https://scigraph.springernature.com/pub.10.1186/1532-429x-13-34

6 August 2017

exact match

0 references

cites work

Extent of RV dysfunction and myocardial infarction assessed by CMR are independent outcome predictors early after STEMI treated with primary angioplasty

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3148987

Continued improvement in myocardial T2* over two years of deferasirox therapy in β-thalassemia major patients with cardiac iron overload

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3148987

Right ventricular volumes and function in thalassemia major patients in the absence of myocardial iron overload

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3148987

Effects of right ventricular ejection fraction on outcomes in chronic systolic heart failure.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3148987

Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3148987

Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3148987

Cell functions impaired by frataxin deficiency are restored by drug-mediated iron relocation

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3148987

Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3148987

Interstudy reproducibility of right ventricular volumes, function, and mass with cardiovascular magnetic resonance.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3148987

28 July 2018

Secondary iron overload

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3148987

Practical management of iron overload.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3148987

The importance of non-transferrin bound iron in disorders of iron metabolism

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3148987

Deferasirox for up to 3 years leads to continued improvement of myocardial T2* in patients with β-thalassemia major.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3148987

Efficacy of deferasirox in reducing and preventing cardiac iron overload in beta-thalassemia

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3148987

Risk/benefit assessment, advantages over other drugs and targeting methods in the use of deferiprone as a pharmaceutical antioxidant in iron loading and non iron loading conditions

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3148987

Myocardial iron loading in patients with thalassemia major on deferoxamine chelation.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3148987

Normal human left and right ventricular and left atrial dimensions using steady state free precession magnetic resonance imaging.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3148987

Role of iron in inducing oxidative stress in thalassemia: Can it be prevented by inhibition of absorption and by antioxidants?

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3148987

Cardiac iron determines cardiac T2*, T2, and T1 in the gerbil model of iron cardiomyopathy.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3148987

Cardiac status in well-treated patients with thalassemia major

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3148987

Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3148987

Normal human right and left ventricular mass, systolic function, and gender differences by cine magnetic resonance imaging.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3148987

Long-term outcome in congenitally corrected transposition of the great arteries

27 September 2018

1 reference

12 December 2020

Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload

1 reference

12 December 2020

Decline in ventricular function and clinical condition after Mustard repair for transposition of the great arteries (a prospective study of 22-29 years)

1 reference

12 December 2020

Survival in medically treated patients with homozygous beta-thalassemia

1 reference

12 December 2020

Right ventricular diastolic function 15 to 35 years after repair of tetralogy of Fallot. Restrictive physiology predicts superior exercise performance

1 reference

12 December 2020

Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure

1 reference

12 December 2020

Additional predictive value of both left and right ventricular ejection fractions on long-term survival in idiopathic dilated cardiomyopathy

1 reference

12 December 2020

Right ventricular ejection fraction is an independent predictor of survival in patients with moderate heart failure

1 reference

12 December 2020

1 reference

12 December 2020

Right ventricular dysfunction assessed by cardiovascular magnetic resonance imaging predicts poor prognosis late after myocardial infarction

1 reference

12 December 2020

Relation of myocardial T2* to right ventricular function in thalassaemia major

1 reference

12 December 2020

Survival in beta-thalassaemia major in the UK: data from the UK Thalassaemia Register

1 reference

12 December 2020

Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure

1 reference

12 December 2020

reason for deprecated rank

Identifiers

DOI

10.1186/1532-429X-13-21

incorrect identifier value

1 reference

Dimensions Publication ID

6 August 2017

10.1186/1532-429X-13-34

0 references

Altmetric DOI

10.1186/1532-429X-13-34

0 references

0 references

1 reference

6 August 2017

1 reference